Product Recalls: November 12, 2025 – December 17, 2025
Health Letter, January 2026
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
CLASS II
bromocriptine mesylate capsules, 5 mg, 30 capsules per bottle. Manufactured by: Zydus Lifesciences Ltd. Lot #: M313934, M313935 or M315615, exp. date: Nov 2025; Lot #: M316809, exp. date: Dec-25; Lot #: M405765, M405763 or M405764, exp. date: Apr-26; Lot #: M414999, M414241, M414307 or M414305, exp. date: Oct-26.
cinacalcet hydrochloride tablets; 30, 60 or 90 mg; 30 tablets per bottle. Manufactured for: Cipla USA, Inc. Lot #: 4PB0109, exp. date: 1/31/2026; Lot #: 5PB0172, exp. date: 1/31/2027; Lot #: 5PB0164, exp. date: 1/31/2027; Lot #: 5PB0183, exp. date: 1/31/2027.
duloxetine delayed-release capsules, 60 mg, 1,000-capsule bottles. Manufactured by: Towa Pharmaceuticals Europe. Lot #: 240947C or 240962C, exp. date: 04/2027; Lot #: 240534C, exp. date: 01/2027; Lot #: 240977C, exp. date: 04/2027.
lanthanum carbonate chewable tablets, 1,000 mg, 10 x 9 bottles per patient pack carton. Manufactured by: Invagen Pharmaceuticals, Inc. Lot #: NB240315, exp. date: 12/31/2025; Lot #: NB240314, exp. date: 12/31/2025.
NIACIN extended-release tablets, 1,000 mg, 90 tablets per bottle. Manufactured by: Kremers Urban Pharmaceuticals, Inc. Lot #: GS044385, exp. date: 10/2025; Lot #: GS044979, exp. date: 10/2025; Lot #: GS045797, exp. date: 12/2025; Lot #: GS046415, exp. date: 12/2025; Lot #: GS047197, exp. date: 02/2026; Lot #: GS047786, exp. date: 02/2026; Lot #: GS048477, exp. date: 02/2026; Lot #: GS049480, exp. date: 03/2026; Lot #: GS048873, exp. date: 03/2026; Lot #: GS049733, exp. date: 03/2026; Lot #: GS050224, exp. date: 03/2026; Lot #: GS050721, exp. date: 03/2026; Lot #: GS050722, exp. date: 03/2026; Lot #: GS051145, exp. date: 03/2026; Lot #: GS051726, exp. date: 03/2026; Lot #: GS052484, exp. date: 03/2026; Lot #: GS053612, exp. date: 04/2026; Lot #: GS054987, exp. date: 05/2026; Lot #: GS054409, exp. date: 05/2026; Lot #: GS055697, exp. date: 05/2026; Lot #: GS056192, exp. date: 05/2026; Lot #: GS056886, exp. date: 05/2026; Lot #: GS058077, exp. date: 05/2026; Lot #: GS057330, exp. date: 05/2026.
sertraline hydrochloride tablets, 100 mg, 90-tablet bottles. Manufactured by: Lupin Pharmaceuticals, Inc. Lot #: QB00865, exp. date: Feb 2028.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.